The promoter of Fresenius Kabi Oncology Ltd (FKO) has indicated its intention to delist the shares of FKO from the BSE and the NSE. Under the delisting offer, the promoter has given Rs130 as an ‘Indicative Price’ which it is willing to pay to buy out the non-promoter shareholders and delist FKO
Excella is an investment advisory solution provider. Excella developed software for financial planners, registered investment advisories, Research analysis , share brokers and mutual fund distributors. Software is cloud based and data is securely protected .
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.